News

liver cancer

The added indications make the treatment the first Y-90 therapy approved for both unresectable hepatocellular carcinoma and metastatic colorectal cancer of the liver.

Thumbnail

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

aktiia hilo band cuffless blood pressure monitor

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

old woman or doctor shaking hands with patient

Care teams should be aware of this difference, even using CT images when possible to look for signs of any potential issues.

rebrand name change marketing

Leaders with the Raleigh, North Carolina-based radiology group said the change comes as the practice continues pursuing expansion through "de novo" imaging centers. 

mergers and acquisitions M&A consolidation puzzle business deal

The Deerfield Beach, Florida-based company is adding MetisMD, “a highly regarded teleradiology provider with deep expertise in musculoskeletal imaging.” 

Congresswoman Rep Beth Van Duyne

“Patients should have the freedom to choose the highest quality care available, and physicians should be allowed to provide it,” said Rep. Beth Van Duyne, R-Texas. 

Veterans Affairs said plans to reduce its workforce by 85,000 have been called off. It has instead undertaken other efforts to improve efficiency. As for the 30,000 jobs it expects to lose by the end of 2025, those will come from early retirements.

A new lawsuit alleges that the LAPD staked out an imaging center due to its higher than usual energy consumption and a “distinct odor” of cannabis coming from the facility. 

Focal pulsed field ablation (PFA) is a safe, effective treatment option for premature ventricular contractions (PVC), according to new data published in Circulation: Arrhythmia and Electrophysiology.[1]

Early data suggest PVC ablation with PFA technology is associated with a high success rate and minimal complications. 

doctor looking at CLTI patient's leg

Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.

cardiologist viewing heart data

Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes. 

Around the web

The added indications make the treatment the first Y-90 therapy approved for both unresectable hepatocellular carcinoma and metastatic colorectal cancer of the liver.

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.